Drugs / MSC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01413035 | Jul 2011 → Dec 2013 | type 2 diabetes mellitus | Shandong University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MSC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01413035 ↗ |
| Modality | Cell therapy | “transplantation treatment using umbilical cord/placenta-derived mesenchymal stem cells” NCT01413035 ↗ |
| Route | Intravenous | “umbilical cord/placenta-derived MSCs are transplanted intravenously.” NCT01413035 ↗ |